|
1
|
Hossain P, Kawar B and El Nahas M: Obesity
and diabetes in the developing world - a growing challenge. N Engl
J Med. 356:213–215. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shi H, Akunuru S, Bierman JC, et al:
Diet-induced obese mice are leptin insufficient after weight
reduction. Obesity. 17:1702–1709. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Seale P and Lazar MA: Brown fat in humans:
turning up the heat on obesity. Diabetes. 58:1482–1484. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dahlman I and Arner P: Obesity and
polymorphisms in genes regulating human adipose tissue. Int J Obes.
31:1629–1641. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sun K, Kusminski CM and Scherer PE:
Adipose tissue remodeling and obesity. J Clin Invest.
121:2094–2101. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cristancho AG and Lazar MA: Forming
functional fat: a growing understanding of adipocyte
differentiation. Nat Rev Mol Cell Biol. 12:722–734. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Spalding KL, Arner E, Westermark PO, et
al: Dynamics of fat cell turnover in humans. Nature. 453:783–787.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tchoukalova YD, Votruba SB, Tchkonia T, et
al: Regional differences in cellular mechanisms of adipose tissue
gain with overfeeding. Proc Natl Acad Sci USA. 107:18226–18231.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hoffstedt J, Arner E, Wahrenberg H, et al:
Regional impact of adipose tissue morphology on the metabolic
profile in morbid obesity. Diabetologia. 53:2496–2503. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Koenen TB, Tack CJ, Kroese JM, et al:
Pioglitazone treatment enlarges subcutaneous adipocytes in
insulin-resistant patients. J Clin Endocrinol Metab. 94:4453–4457.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Veilleux A, Caron-Jobin M, Noel S, et al:
Visceral adipocyte hypertrophy is associated with dyslipidemia
independent of body composition and fat distribution in women.
Diabetes. 60:1504–1511. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Meier JJ: GLP-1 receptor agonists for
individualized treatment of type 2 diabetes mellitus. Nat Rev
Endocrinol. 8:728–742. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kielgast U, Holst JJ and Madsbad S:
Antidiabetic actions of endogenous and exogenous GLP-1 in type 1
diabetic patients with and without residual β-cell function.
Diabetes. 60:1599–1607. 2011.PubMed/NCBI
|
|
14
|
Ben-Shlomo S, Zvibel I, Shnell M, et al:
Glucagon-like peptide-1 reduces hepatic lipogenesis via activation
of AMP-activated protein kinase. J Hepatol. 54:1214–1223. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chai W, Dong Z, Wang N, et al:
Glucagon-like peptide 1 recruits microvasculature and increases
glucose use in muscle via a nitric oxide-dependent mechanism.
Diabetes. 61:888–896. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gao H, Wang X, Zhang Z, et al: GLP-1
amplifies insulin signaling by up-regulation of IRβ, IRS-1 and
Glut4 in 3T3-L1 adipocytes. Endocrine. 32:90–95. 2007.PubMed/NCBI
|
|
17
|
Lee YS, Park MS, Choung JS, et al:
Glucagon-like peptide-1 inhibits adipose tissue macrophage
infiltration and inflammation in an obese mouse model of diabetes.
Diabetologia. 55:2456–2468. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
He M, Su H, Gao W, et al: Reversal of
obesity and insulin resistance by a non-peptidic glucagon-like
peptide-1 receptor agonist in diet-induced obese mice. PLoS One.
5:e142052010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bass J and Takahashi JS: Circadian
integration of metabolism and energetics. Science. 330:1349–1354.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cristancho AG and Lazar MA: Forming
functional fat: a growing understanding of adipocyte
differentiation. Nat Rev Mol Cell Biol. 12:722–734. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim GS, Park HJ, Woo JH, et al: Citrus
aurantium flavonoids inhibit adipogenesis through the Akt signaling
pathway in 3T3-L1 cells. BMC Complement Altern Med. 12:312012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Choi SS, Cha BY, Iida K, et al: Honokiol
enhances adipocyte differentiation by potentiating insulin
signaling in 3T3-L1 preadipocytes. J Nat Med. 65:424–430. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang M, Ikeda K, Xu JW, et al: Genistein
suppresses adipogenesis of 3T3-L1 cells via multiple signal
pathways. Phytother Res. 23:713–718. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fischer-Posovszky P, Tews D, Horenburg S,
et al: Differential function of Akt1 and Akt2 in human adipocytes.
Mol Cell Endocrinol. 358:135–143. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Polvani S, Tarocchi M and Galli A: PPARγ
and oxidative stress: Con(β) catenating NRF2 and FOXO. PPAR Res.
2012:6410872012.
|
|
26
|
Dowell P, Otto TC, Adi S and Lane MD:
Convergence of peroxisome proliferator-activated receptor γ and
foxo1 signaling pathways. J Biol Chem. 278:45485–45491. 2003.
|
|
27
|
Sanz C, Vázquez P, Blázquez C, Barrio PA,
Alvarez Mdel M and Blázquez E: Signaling and biological effects of
glucagon-like peptide 1 on the differentiation of mesenchymal stem
cells from human bone marrow. Am J Physiol Endocrinol Metab.
298:E634–E643. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Challa TD, Beaton N, Arnold M, et al:
Regulation of adipocyte formation by GLP-1/GLP-1R signaling. J Biol
Chem. 287:6421–6430. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kang JG, Park CY, Ihm SH, et al:
Mechanisms of adipose tissue redistribution with rosiglitazone
treatment in various adipose depots. Metabolism. 59:46–53. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dubuisson O, Dhurandhar EJ, Krishnapuram
R, et al: PPARgamma-independent increase in glucose uptake and
adiponectin abundance in fat cells. Endocrinology. 152:3648–3660.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chang YC and Cho HJ: Ascofuranone
stimulates expression of adiponectin and peroxisome proliferator
activated receptor through the modulation of mitogen activated
protein kinase family members in 3T3-L1, murine pre-adipocyte cell
line. Biochem Biophys Res Commun. 422:423–428. 2012. View Article : Google Scholar
|
